Plain-English translation of NCT06657209 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing two medications— and —to see if they can help improve blood sugar control and metabolic health in people with type 2 diabetes who have a normal body weight. Researchers want to understand how these treatments affect the way fat is distributed in the body and how the body uses insulin. This research is important because most diabetes studies focus on people who are overweight, and doctors know very little about how to best treat diabetes in people with normal weight.
Type 2 diabetes in normal-weight people is often overlooked in medical research and treatment planning, even though it affects a meaningful number of patients. By studying how these medications work in this specific group, researchers hope to develop more personalized and effective treatment strategies that address the unique biology of normal-weight diabetes.
You likely qualify if…
You likely don't qualify if…
If you are in the diabetes group, you will have baseline testing to measure your blood sugar, body composition, and metabolic health. Then you will take one of the medications for 16 weeks, followed by retesting. After a 5-week break (washout period), you will take the second medication for another 16 weeks with final testing. If you are in the control group (people without diabetes), you will complete baseline testing only. Throughout the study, you will visit the research clinic multiple times for blood tests, body measurements, and other assessments to track how the treatments affect your metabolism.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States